ACS chemical neuroscience molecule spotlight on fanapt

Research output: Contribution to journalShort survey

6 Citations (Scopus)

Abstract

The new mixed dopamaine D2/serotonin 5-HT2A antagonist, Fanapt (iloperidone), was approved by the FDA on May 6th, 2009 for the treatment of schizophrenia in adults.

Original languageEnglish (US)
Number of pages1
JournalACS Chemical Neuroscience
Volume1
Issue number6
DOIs
StatePublished - Jun 16 2010

Fingerprint

Neurosciences
Serotonin 5-HT2 Receptor Antagonists
Molecules
Serotonin
Schizophrenia
iloperidone

ASJC Scopus subject areas

  • Physiology
  • Biochemistry
  • Cognitive Neuroscience
  • Cell Biology

Cite this

ACS chemical neuroscience molecule spotlight on fanapt. / Hopkins, Corey R.

In: ACS Chemical Neuroscience, Vol. 1, No. 6, 16.06.2010.

Research output: Contribution to journalShort survey

@article{9b8916ac69604ce3af0c75203a727371,
title = "ACS chemical neuroscience molecule spotlight on fanapt",
abstract = "The new mixed dopamaine D2/serotonin 5-HT2A antagonist, Fanapt (iloperidone), was approved by the FDA on May 6th, 2009 for the treatment of schizophrenia in adults.",
author = "Hopkins, {Corey R}",
year = "2010",
month = "6",
day = "16",
doi = "10.1021/cn100024g",
language = "English (US)",
volume = "1",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "6",

}

TY - JOUR

T1 - ACS chemical neuroscience molecule spotlight on fanapt

AU - Hopkins, Corey R

PY - 2010/6/16

Y1 - 2010/6/16

N2 - The new mixed dopamaine D2/serotonin 5-HT2A antagonist, Fanapt (iloperidone), was approved by the FDA on May 6th, 2009 for the treatment of schizophrenia in adults.

AB - The new mixed dopamaine D2/serotonin 5-HT2A antagonist, Fanapt (iloperidone), was approved by the FDA on May 6th, 2009 for the treatment of schizophrenia in adults.

UR - http://www.scopus.com/inward/record.url?scp=77953667709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953667709&partnerID=8YFLogxK

U2 - 10.1021/cn100024g

DO - 10.1021/cn100024g

M3 - Short survey

VL - 1

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 6

ER -